HomeInsightsStock Comparison

Titan Biotech Ltd vs Windlas Biotech Ltd Stock Comparison

Titan Biotech Ltd vs Windlas Biotech Ltd Stock Comparison

Last Updated on: Jul 05, 2025

Key Highlights

  • The Latest Trading Price of Titan Biotech Ltd is ₹ 457.75 as of 04 Jul 15:30.
  • The P/E Ratio of Titan Biotech Ltd changed from 5 on March 2020 to 17.6 on March 2024 . This represents a CAGR of 28.62% over 5 yearsThe P/E Ratio of Windlas Biotech Ltd changed from 12 on March 2022 to 18.3 on March 2024 . This represents a CAGR of 15.10% over 3 years.
  • The Market Cap of Titan Biotech Ltd changed from ₹ 35.24 crore on March 2020 to ₹ 436.49 crore on March 2024 . This represents a CAGR of 65.42% over 5 yearsThe Market Cap of Windlas Biotech Ltd changed from ₹ 457.9 crore on March 2022 to ₹ 1065 crore on March 2024 . This represents a CAGR of 32.52% over 3 years.
  • The revenue of Titan Biotech Ltd for the Mar '25 is ₹ 36.55 crore as compare to the Dec '24 revenue of ₹ 39.87 crore. This represent the decline of -8.33% The revenue of Windlas Biotech Ltd for the Mar '25 is ₹ 207.64 crore as compare to the Dec '24 revenue of ₹ 199.13 crore. This represent the growth of 4.27%.
  • The ebitda of Titan Biotech Ltd for the Mar '25 is ₹ 5.95 crore as compare to the Dec '24 ebitda of ₹ 6.44 crore. This represent the decline of -7.61% The ebitda of Windlas Biotech Ltd for the Mar '25 is ₹ 30.49 crore as compare to the Dec '24 ebitda of ₹ 28.74 crore. This represent the growth of 6.09%.
  • The net profit of Titan Biotech Ltd changed from ₹ 5.41 crore to ₹ 3.77 crore over 8 quarters. This represents a CAGR of -16.52% The net profit of Windlas Biotech Ltd changed from ₹ 12.07 crore to ₹ 16.28 crore over 8 quarters. This represents a CAGR of 16.14% .
  • The Dividend Payout of Titan Biotech Ltd changed from 13.32 % on March 2020 to 6.98 % on March 2024 . This represents a CAGR of -12.12% over 5 yearsThe Dividend Payout of Windlas Biotech Ltd changed from 19.79 % on March 2022 to 19.68 % on March 2024 . This represents a CAGR of -0.19% over 3 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Titan Biotech Ltd

  • Titan Biotech Ltd., the New Delhi based company is into manufacture of Biological Peptones, Extracts and Dehydrated Culture media which are very conducive for the growth of micro organisms.
  • They are primarily used in the development and growth of micro organisms in clinical diagnosis production of vaccines antibiotics antisera etc, Checking the sensitivity of antibiotics in pharmaceutical industry, checking the bacterial contamination in food & water, tissue culture laboratories and in the departments of microbiology & botony in medical colleges/universities. The company uses Meat, Bile, Pancreatic, Liver, Blood, Brain, Heart and other parts of animals souced from slaughter house and other vegetable products like soya, casein etc. converting them into free flowing powder to produce Peptones, Extracts and Hydrolysates which are further used in manufacturing of Dehydrated Culture Media and as raw material in pharma health products and other industries.

About Windlas Biotech Ltd

  • Windlas Biotech Limited (formerly known as Windlas Biotech Private Limited) was incorporated in 2001.
  • The Company converted from a Private Limited Company to a Public Limited Company and the name of the Company was changed to Windlas Biotech Limited'.
  • A fresh Certificate of Incorporation dated April 15, 2021, granted by the Registrar of Companies, Uttarakhand at Dehradun. The Company is engaged in manufacturing and trading of pharmaceutical products.
  • TheIR manufacturing facilities are located at Dehradun in Uttarakhand.
  • It also has a sales force and distribution network spread across 14 states.

Titan Biotech Ltd News Hub

News

Board of Titan Biotech recommends final dividend

Titan Biotech announced that the Board of Directors of the Company at its meeting held on ...

Read more

30 May 2025 18:38

News

Titan Biotech to conduct board meeting

Titan Biotech will hold a meeting of the Board of Directors of the Company on 30 May 2025....

Read more

27 May 2025 14:34

News

Titan Biotech to hold board meeting

Titan Biotech will hold a meeting of the Board of Directors of the Company on 12 February ...

Read more

04 Feb 2025 12:34

News

Titan Biotech schedules board meeting

Titan Biotech will hold a meeting of the Board of Directors of the Company on 12 November ...

Read more

06 Nov 2024 18:13

News

Titan Biotech to conduct AGM

Titan Biotech announced that the Annual General Meeting (AGM) of the company will be held ...

Read more

11 Sep 2024 10:35

News

Titan Biotech to hold board meeting

Titan Biotech will hold a meeting of the Board of Directors of the Company on 13 August 20...

Read more

05 Aug 2024 14:43

Windlas Biotech Ltd News Hub

News

Windlas Biotech to convene AGM

Windlas Biotech announced that the 24th Annual General Meeting(AGM) of the company will be...

Read more

04 Jul 2025 16:39

News

Windlas Biotech Ltd Spurts 3.25%

Windlas Biotech Ltd rose 3.25% today to trade at Rs 927. The BSE Healthcare index is up 0....

Read more

19 Jun 2025 09:30

News

Windlas Biotech Ltd Slips 4.88%, BSE Healthcare index Shed 1.03%

Windlas Biotech Ltd fell 4.88% today to trade at Rs 923. The BSE Healthcare index is down ...

Read more

23 May 2025 09:30

News

Board of Windlas Biotech recommends final dividend

Windlas Biotech announced that the Board of Directors of the Company at its meeting held o...

Read more

22 May 2025 21:08

News

Windlas Biotech to announce Quarterly Result

Windlas Biotech will hold a meeting of the Board of Directors of the Company on 22 May 202...

Read more

15 May 2025 12:29

News

Windlas Biotech receives affirmation in credit ratings from ICRA

Windlas Biotech has received reaffirmation in credit ratings from ICRA at ICRA A+; Stable/...

Read more

08 Apr 2025 15:08

SWOT Analysis Of Windlas Biotech Ltd

Strength

5

S

Weakness

3

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Titan Biotech Ltd

Strength

1

S

Weakness

0

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Windlas Biotech Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Titan Biotech Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Titan Biotech Ltd and Windlas Biotech Ltd

Which company has a larger market capitalization, Titan Biotech Ltd or Windlas Biotech Ltd?

Market cap of Titan Biotech Ltd is 378 Cr while Market cap of Windlas Biotech Ltd is 1,882 Cr

What are the key factors driving the stock performance of Titan Biotech Ltd and Windlas Biotech Ltd?

The stock performance of Titan Biotech Ltd and Windlas Biotech Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Titan Biotech Ltd and Windlas Biotech Ltd?

As of July 5, 2025, the Titan Biotech Ltd stock price is INR ₹457.75. On the other hand, Windlas Biotech Ltd stock price is INR ₹900.5.

How do dividend payouts of Titan Biotech Ltd and Windlas Biotech Ltd compare?

To compare the dividend payouts of Titan Biotech Ltd and Windlas Biotech Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions